PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

40,350 stories, page 400 of 673

Advanced search
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Cancer Clinical Trial Eligibility Criteria: Performance Status; Guidance for Industry, Institutional Review Boards, and Clinical Investigators; Availability

The Food and Drug Administration (FDA, the Agency, or we) is announcing the availability of a final...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Center for Scientific Review; Notice of Closed Meeting

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Designation of a Class of Employees for Addition to the Special Exposure Cohort

HHS gives notice of a decision to designate a class of employees from the Savannah River Site in Aik...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Notice of Final Issuance on the Adoption of Administration for Native Americans Program Policies and Procedures

ANA is issuing final interpretive rules, general statements of policy, and rules of agency organizat...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Pediatric Advisory Committee (PAC); Notice of Meeting; Establishment of a Public Docket; Request for Comments

The Food and Drug Administration (FDA or the Agency) announces a forthcoming public advisory committ...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Agency Information Collection Activities; Proposed Collection; Comment Request; Expanded Access to Investigational Drugs for Treatment Use

The Food and Drug Administration (FDA, Agency, or we) is announcing an opportunity for public commen...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Fee Rate for Using a Priority Review Voucher in Fiscal Year 2026; Correction

The Food and Drug Administration (FDA) is amending a notice entitled "Fee Rate for Using a Priority...

Federal RegisterOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Sugammadex

Official structured record identifier: d9d4467c-97ae-462a-9722-cc8d62db3e83.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Aspercreme Lidocaine with Rosemary and Mint

Official structured record identifier: 9d40bfea-85d0-4943-83e9-0c16e79a011c.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Gabapentin

Official structured record identifier: 725878fa-1e2f-4fee-a9e1-a6e102c79625.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Irbesartan

Official structured record identifier: 5b259fdd-ca4c-49c9-a50d-86066f5b0746.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: It Bag Strawberry Love Hand Sanitizer

Official structured record identifier: 57adfb22-cb7a-39e7-e063-6294a90a3079.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: It Bag Cherry Kiss Hand Sanitizer

Official structured record identifier: 57adec54-6099-0694-e063-6394a90a4a0f.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: It Bag Vanilla Sugar Hand Sanitizer

Official structured record identifier: 57adcf08-9785-016d-e063-6294a90aa8d4.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Isopropyl Alcohol

Official structured record identifier: 57acc1ff-2564-1e61-e063-6394a90a3c91.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: 70% Isopropyl Alcohol

Official structured record identifier: 57ac6fef-21de-e214-e063-6394a90a6c9e.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: DECONIMO Reconstitution

Official structured record identifier: 57ab9b1c-9a18-3786-e063-6394a90a2c63.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Ponamfo ANTIFUNGAL TREATMENT PEN

Official structured record identifier: 57a9ccff-270b-9769-e063-6394a90a5e0c.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Nicotine Stop Smoking AID Step3

Official structured record identifier: 57a8b8d3-0acc-bf91-e063-6294a90a99f8.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Nicotine Stop Smoking AID Step2

Official structured record identifier: 57a8a71b-7213-ab7d-e063-6394a90a5130.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: SKINTIFIC 3X ACID INTENSIVE ACNE TREATMENT

Official structured record identifier: 57a7c929-31f5-ef82-e063-6394a90ab9af.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Nicotine Stop Smoking AID Step1

Official structured record identifier: 57a7a614-5f23-258b-e063-6294a90a94b1.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Rosuvastatin calcium

Official structured record identifier: 568a782b-1621-5e59-e063-6294a90a7fef.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: FUNGAL NAIL PATCHES

Official structured record identifier: 5240412c-4257-8e9d-e063-6394a90a0a12.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: PERCOCET

Official structured record identifier: 4dd36cf5-8f73-404a-8b1d-3bd53bd90c25.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Aminocaproic acid

Official structured record identifier: 4a22e559-2dac-42d7-af8d-eb0ebbc2f76d.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Native Mineral Suncare Broad Spectrum SPF 30 Unscented

Official structured record identifier: 3a89238b-d1ee-d7fa-e063-6294a90ae55f.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: INFLECTRA

Official structured record identifier: 37eaca10-d812-48bc-8b8e-b836bfa9968f.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: LidoPro Patch (Lidocaine 4%, Menthol 1%)

Official structured record identifier: 2b4d2105-b7ad-2695-e063-6394a90a999b.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: BENZTROPINE MESYLATE

Official structured record identifier: 241479dd-91bf-455a-80a1-1bb2d1c8156d.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Ibuprofen

Official structured record identifier: 21567c0f-abba-4a40-a0b9-5ce49b3d9648.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Oxybutynin Chloride

Official structured record identifier: 1a08a16a-f16d-4ef1-95bb-6943bcae0737.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Metformin Hydrochloride

Official structured record identifier: 1503bbe4-0ac5-479b-9900-d38e49236bf0.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: SUGAMMADEX SODIUM

Official structured record identifier: 0379799d-b678-4eb1-8f15-7dd183ee2a6e.

openFDA Drug LabelsOriginal source
🇺🇸Researchonlinejcf.comTier 2 · Direct publisher

Stepping it Up on Temporary Mechanical Circulatory Support: Mobilization and Prehabilitation of Patients in ICUs

Journal of Cardiac FailureOriginal source
🇨🇦Industryir.bauschhealth.comTier 1 · Company source

Pr ELIDEL ® (pimecrolimus) cream Now Reimbursed Under Alberta’s Public Drug Plan for Eligible Patients with Mild to Moderate Atopic Dermatitis

Bausch Health (IR News)Original source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Review Article: Accelerating Coeliac Disease Clinical Trials-Beyond Celiac Meeting With Industry, Academics, Patients and the FDA.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Antacid co-treatment and pregnane X receptor genetic polymorphisms are survival determinants in patients treated with palbociclib.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Economic Impact of Multidisciplinary Pre-operative Diabetes Care Versus Usual Care in Adults Undergoing Elective Non-cardiac Surgery in Australia: A Trial-Based Analysis.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Clinical outcomes of upadacitinib continuation vs withdrawal in giant cell arteritis through 2 years.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Effects of ursodeoxycholic acid on statin-induced impaired glucose tolerance: study protocol for a randomized controlled trial.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Health databases and early identification of autism spectrum disorder: a scoping review.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Baloxavir marboxil, favipiravir, or oseltamivir in patients with non-severe symptomatic seasonal influenza (AD ASTRA): a phase 2, open-label, adaptive, randomised controlled trial.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Dual role of macrophage heterogeneity in allergic inflammation: from mechanism to targeted therapy.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

The global demand and potential public health impact of oral antiviral treatment stockpile for influenza pandemics.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

A randomized phase 2 trial of socrodeucitinib in moderate-to-severe plaque psoriasis.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Impact of Albuminuria-Lowering Treatments on Cardiovascular Predictive Ceramides in Diabetes: Post Hoc Analysis of the ROTATE Trials.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Emotional problems and dysregulation in children/youth with ADHD: predictive and moderating effects in a randomized controlled trial of methylphenidate and neurofeedback.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Multimodal Therapy With Metformin, Inositol and Dietary Restriction Improves Insulin Resistance and Endocrine Outcomes in Women With Polyendocrine Metabolic Ovarian Syndrome: A Randomized Controlled Trial.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Inavolisib: a second-generation PI3Kα inhibitor in HR+/HER2-negative breast cancer.

Europe PMCOriginal source
🌍Researchdoi.orgTier 1 · Research record

Recent Developments in Resilience Theory and Research: A Review Across Clinical, Positive, and Organizational Psychology

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Over 600 I.U. of insulin per day in a pregnant woman with congenital generalized lipodystrophy — clinical vignette

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

The Mediterranean Dietary Pattern Ameliorates Nonalcoholic Fatty Liver Disease: Clinical Evidence, Biological Mechanisms and Practical Implications

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Advances in liver transplant oncology: Biology-driven selection, systemic therapy integration, and future trial frameworks

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Uso do Retalho Toracodorsal Lateral na Reconstrução Após Mastectomia

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Gratification Disorder (Infantile masturbation) from 6 Months to 2 Years & 8 months: A Case Analysis of Clinical Progression, Diagnostic Differentiation, and Behavioral Management

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Equine Locoregional Anaesthesia and Analgesia: Pharmacology, Techniques, Clinical Applications, and Emerging Evidence in Thoracoabdominal Wall and Reproductive Tract Procedures

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Clinical Outcomes After Same-Agent Double-Dose Anti-VEGF Escalation in Eyes with a Suboptimal Response to Standard-Dose Treatment for Exudative Macular Diseases: A Real-World Pre–Post Study

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Correction: Guadalajara et al. Impact on Clinical- and Patient-Reported Outcomes Measures of an Organ Preservation-Based Therapeutic Strategy in Locally Advanced Rectal Cancer: The FOREST Project. J. Clin. Med. 2026, 15, 844

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Lithium in Bipolar Disorder: Renal Mechanisms, Nephrotoxicity Phenotypes, and a Shared-Care Pathway for Clinical Practice

CrossrefOriginal source